The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase IIIb randomized study of lenalidomide plus rituximab (R2) followed by maintenance in relapsed/refractory NHL: Analysis of patients with double-refractory or early relapsed follicular lymphoma (FL).
 
David Jacob Andorsky
Honoraria - Celgene
Research Funding - Bristol-Myers Squibb; Celgene; CTI; Gilead Sciences
 
Abdulraheem Yacoub
Consulting or Advisory Role - Incyte; Sandoz; Seagen
Speakers' Bureau - Incyte; Seagen
 
Jason M. Melear
No Relationships to Disclose
 
Morton Coleman
Consulting or Advisory Role - Bayer; Gilead Sciences
Speakers' Bureau - Celgene; Gilead Sciences; Pharmacyclics
Research Funding - Bayer; Celgene; Gilead Sciences; Merck; Pharmacyclics
 
Kathryn S. Kolibaba
Honoraria - TG Therapeutics
Consulting or Advisory Role - Gilead Sciences; Seagen
Research Funding - Acerta Pharma (Inst); Amgen (Inst); Celgene (Inst); Cell Therapeutics (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Novartis (Inst); Pharmacyclics (Inst); Seagen (Inst); TG Therapeutics (Inst)
Travel, Accommodations, Expenses - TG Therapeutics
 
Heather Dawn Brooks
No Relationships to Disclose
 
Jacob D. Bitran
No Relationships to Disclose
 
Suzanne R. Fanning
Stock and Other Ownership Interests - Celgene; Gilead Sciences; TG Therapeutics
Speakers' Bureau - Celgene; Takeda
 
Frederick Lansigan
Research Funding - Spectrum Pharmaceuticals; Teva
 
Justin L. Ricker
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Kenneth A. Foon
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Travel, Accommodations, Expenses - Celgene
 
Dongfang Liu
Employment - Bristol-Myers Squibb (I); Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb (I); Celgene
 
Mary Llorente
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Jiahui Li
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Jeff Porter Sharman
Leadership - US Oncology
Consulting or Advisory Role - Celgene; Genentech; Gilead Sciences; Pharmacyclics; TG Therapeutics
Speakers' Bureau - Gilead Sciences
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)
Expert Testimony - Gilead Sciences